SAREPTA THERAPEUTICS INC (SRPT) Stock Analyst Ratings
NASDAQ:SRPT - Nasdaq - US8036071004 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 83% to SRPT. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 58.82. This target is 192.92% above the current price.
SRPT was analyzed by 32 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about SRPT.
In the previous month the buy percentage consensus was at a similar level.
SRPT was analyzed by 32 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-06-20 | William Blair | Downgrade | Outperform -> Market Perform |
| 2025-06-20 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-06-18 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-06-17 | Wolfe Research | Initiate | Peer Perform |
| 2025-06-17 | Deutsche Bank | Maintains | Hold -> Hold |
| 2025-06-17 | Barclays | Maintains | Overweight -> Overweight |
| 2025-06-17 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-06-17 | Baird | Maintains | Outperform -> Outperform |
| 2025-06-17 | Goldman Sachs | Downgrade | Buy -> Neutral |
| 2025-06-17 | Morgan Stanley | Downgrade | Overweight -> Equal-Weight |
| 2025-06-16 | BMO Capital | Downgrade | Outperform -> Market Perform |
| 2025-06-16 | Needham | Maintains | Buy -> Buy |
| 2025-06-16 | B of A Securities | Downgrade | Buy -> Neutral |
| 2025-06-16 | Piper Sandler | Downgrade | Overweight -> Neutral |
| 2025-06-16 | Jefferies | Maintains | Buy -> Buy |
| 2025-06-16 | HC Wainwright & Co. | Downgrade | Neutral -> Sell |
| 2025-06-06 | ScotiaBank | Upgrade | Sector Perform -> Sector Outperform |
| 2025-05-22 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2025-05-20 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-05-08 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-05-07 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2025-05-07 | Guggenheim | Maintains | Buy -> Buy |
| 2025-05-07 | Needham | Maintains | Buy -> Buy |
| 2025-05-07 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-05-07 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2025-05-07 | Goldman Sachs | Maintains | Buy -> Buy |
| 2025-05-07 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-05-07 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-05-07 | HC Wainwright & Co. | Maintains | Neutral -> Neutral |
| 2025-04-21 | Piper Sandler | Maintains | Overweight -> Overweight |